Cleveland HeartLab Overview
- Year Founded
-
2009

- Status
-
Acquired/Merged
- Employees
-
83

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$94M
Cleveland HeartLab General Information
Description
Operator of a clinical reference laboratory specializing in cardiovascular disease prevention intended to improve the early identification of those with cardiovascular disease (CVD) risk. The company focuses on novel molecular bio-marker technologies and the creation of proprietary diagnostic tests for managing and reducing inflammation. It offers clinical laboratory services, such as cardiovascular disease (CVD) inflammatory panel, advanced CVD risk profile, lipid panel, and future test services.
Contact Information
Website
www.clevelandheartlab.com(Operating Subsidiary)
Corporate Office
- 6701 Carnegie Avenue
- Suite 500
- Cleveland, OH 44103
- United States
Corporate Office
- 6701 Carnegie Avenue
- Suite 500
- Cleveland, OH 44103
- United States
Cleveland HeartLab Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Merger/Acquisition | 01-Dec-2017 | $94M | Completed | Generating Revenue | ||
7. Later Stage VC (Series D) | 01-Apr-2016 | Completed | Generating Revenue | |||
6. Later Stage VC (Series C) | 08-Jul-2014 | Completed | Generating Revenue | |||
5. Early Stage VC (Series B1) | 17-Oct-2012 | Completed | Generating Revenue | |||
4. Early Stage VC (Series B) | 23-Aug-2011 | Completed | Generating Revenue | |||
3. Early Stage VC | 02-Mar-2010 | Completed | Startup | |||
2. Early Stage VC | 01-Dec-2009 | $2.5M | $7M | Completed | Startup | |
1. Early Stage VC (Series A) | $4.5M | $4.5M | Completed | Startup |
Cleveland HeartLab Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D | ||||||||
Series C | ||||||||
Series B1 | ||||||||
Series B | 19,976,689 | $0.000100 | 6% | $0.92 | $0.92 | 1x | $0.92 | 28.79% |
Series A | 12,569,356 | $0.000100 | 6% | $0.92 | $0.92 | 1x | $0.92 | 18.12% |
Cleveland HeartLab Comparisons
Industry
Financing
Details
Cleveland HeartLab Competitors (29)
One of Cleveland HeartLab’s 29 competitors is ARUP Laboratories, a Corporation company based in Salt Lake City, UT.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ARUP Laboratories | Corporation | Salt Lake City, UT | ||||
Bioquintex Laboratories | Private Equity-Backed | Lee's Summit, MO | ||||
SpectraCell Laboratories | Formerly PE-Backed | Houston, TX | ||||
Dynacare Healthcare Services | Formerly PE-Backed | Brampton, Canada | ||||
NMS Labs | Corporation | Horsham, PA |
Cleveland HeartLab Patents
Cleveland HeartLab Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11237167-B2 | Lp-pla2 assays and composition with detergent | Active | 24-Jan-2017 | ||
US-20180209977-A1 | Lp-pla2 assays and composition with detergent | Active | 24-Jan-2017 | ||
US-20220155302-A1 | Lp-pla2 assays and composition with detergent | Pending | 24-Jan-2017 | ||
JP-2022025100-A | Biomarker panel detection of hdl-related proteins | Active | 21-Jul-2016 | ||
EP-3488241-A4 | Hdl-associated protein biomarker panel detection | Active | 21-Jul-2016 | G01N33/92 |
Cleveland HeartLab Signals
Cleveland HeartLab Former Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Abundance Partners | Venture Capital | Minority | ||
Advantage Capital | PE/Buyout | Minority | ||
Bratenahl Capital Partners | Family Office | Minority | ||
Excel Venture Management | Venture Capital | Minority | ||
Frantz Medical Ventures | Corporate Venture Capital | Minority |
Cleveland HeartLab Investments & Acquisitions (2)
Cleveland HeartLab’s most recent deal was a Merger/Acquisition with True Health Diagnostics for . The deal was made on 01-Oct-2019.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
True Health Diagnostics | 01-Oct-2019 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
Cleveland HeartLab (MIRISK Heart Attack Risk Assessment Tool) | 07-Jan-2015 | Corporate Asset Purchase | Buildings and Property |
Cleveland HeartLab FAQs
-
When was Cleveland HeartLab founded?
Cleveland HeartLab was founded in 2009.
-
Where is Cleveland HeartLab headquartered?
Cleveland HeartLab is headquartered in Cleveland, OH.
-
What is the size of Cleveland HeartLab?
Cleveland HeartLab has 83 total employees.
-
What industry is Cleveland HeartLab in?
Cleveland HeartLab’s primary industry is Laboratory Services (Healthcare).
-
Is Cleveland HeartLab a private or public company?
Cleveland HeartLab is a Private company.
-
What is the current valuation of Cleveland HeartLab?
The current valuation of Cleveland HeartLab is
. -
What is Cleveland HeartLab’s current revenue?
The current revenue for Cleveland HeartLab is
. -
How much funding has Cleveland HeartLab raised over time?
Cleveland HeartLab has raised $56.5M.
-
Who are Cleveland HeartLab’s investors?
Abundance Partners, Advantage Capital, Bratenahl Capital Partners, Excel Venture Management, and Frantz Medical Ventures are 5 of 12 investors who have invested in Cleveland HeartLab.
-
Who are Cleveland HeartLab’s competitors?
ARUP Laboratories, Bioquintex Laboratories, SpectraCell Laboratories, Dynacare Healthcare Services, and NMS Labs are some of the 29 competitors of Cleveland HeartLab.
-
When was Cleveland HeartLab acquired?
Cleveland HeartLab was acquired on 01-Dec-2017.
-
Who acquired Cleveland HeartLab?
Cleveland HeartLab was acquired by Quest Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »